Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tiotropium (9mcg)
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Inhaler
Packaging Type
Metered Dose with Carton and Leaflet
Packaging
200
Price
₹594/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tioprime Inhaler is a long-acting bronchodilator specifically formulated to manage chronic obstructive pulmonary disease (COPD) and related conditions such as chronic bronchitis and emphysema. Its active ingredient, Tiotropium, belongs to the anticholinergic class of medications, which work by relaxing airway muscles and improving airflow. This inhaler is designed to help reduce symptoms like breathlessness, wheezing, and coughing while preventing disease exacerbations.
The Tioprime Inhaler delivers a consistent and precise dose of Tiotropium directly to the lungs, ensuring effective symptom control with minimal systemic side effects. Its once-daily usage provides 24-hour relief, making it a convenient option for patients with long-term respiratory conditions. This inhaler can significantly enhance quality of life and functional breathing capacity when used as prescribed.
Common side effects may include dry mouth, throat irritation, cough, dizziness, and headaches. In rare cases, urinary retention, palpitations, or worsening of narrow-angle glaucoma may occur.
Indicated for the maintenance treatment of COPD, including chronic bronchitis and emphysema, to relieve airway obstruction and improve breathing.
Use under the supervision of a healthcare professional. Do not exceed the prescribed dose. If breathing difficulties persist or worsen, seek immediate medical attention.
Store at room temperature, below 25°C. Keep away from direct sunlight, heat, and moisture. Always replace the cap after use and keep it out of reach of children.
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Tiotropium (18mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Salmeterol (25mcg) + Fluticasone Propionate (250mcg)
Composition : Salmeterol (25mcg) + Fluticasone Propionate (500mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (500 mcg)
Composition : Salmeterol (50mcg) + Fluticasone Propionate (250mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tiotropium 9 mcg Inhaler is a long-acting muscarinic antagonist (LAMA) used for the management of chronic obstructive pulmonary disease (COPD) and sometimes as maintenance therapy in chronic asthma. It works by relaxing airway muscles and improving airflow, helping patients breathe more easily and reducing exacerbations. It is a strong respiratory and chronic pulmonology segment product, mainly prescribed for long-term control rather than acute relief.
Medical distributors and wholesalers can benefit from consistent and long-term demand from pulmonologists, chest physicians, and hospitals. COPD is a chronic progressive disease requiring daily medication, ensuring regular refill prescriptions, stable institutional sales, and long-term patient dependency.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in respiratory, pulmonology, and inhalation therapy segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high chronic disease burden, long-term prescription continuity, and strong hospital + specialist-driven demand, making it a stable, high-value, and repeat-order pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in respiratory and inhalation therapy products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the pulmonology and chronic respiratory segment.